← Eichor
Condition: Disorder In Complete Remission In Response To Treatment Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Disorder In Complete Remission In Response To Treatment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · 306 location(s) · Merck Sharp & Dohme LLC · NCT06393374Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
NA · 16 location(s) · Centre Leon Berard · NCT04055220Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06939127Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With P
Phase 3 · 158 location(s) · Eastern Cooperative Oncology Group · NCT06724237RGL-305+ Lymphoma + Exploratory Clinical Study
NA · 1 location(s) · Fudan University · NCT07006012Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced
Phase 2 · 1 location(s) · Renmin Hospital of Wuhan University · NCT05563012Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer
Phase N/A · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06364371Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer
Phase N/A · 1 location(s) · Atlas University · NCT07289282Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed
Phase 2 · 6 location(s) · Academic and Community Cancer Research United · NCT06238648Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Phase 1 · 1 location(s) · University of Oklahoma · NCT06130995Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · 266 location(s) · National Cancer Institute (NCI) · NCT06498635LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer
Phase 2 · 10 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06831955DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy
NA · 1 location(s) · The Netherlands Cancer Institute · NCT05416164
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.